enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Novocure's device shown to slow cancer progression in the ...

   www.aol.com/news/novocures-lung-cancer-device...

   (Reuters) -Novocure's therapy met the main goal of a late-stage trial of slowing the progression of cancer to the brain in patients with a type of lung cancer, the company said on Wednesday ...

3. NovoCure's Tumor-Treating Electric Fields Shows Promise In ...

   www.aol.com/finance/novocures-tumor-treating...

   On Monday, NovoCure Ltd (NASDAQ:NVCR) and Zai Lab Limited (NASDAQ:ZLAB) revealed topline data from the Phase 3 PANOVA-3 trial of Tumor-Treating Fields (TTFields) therapy concomitantly with ...

4. Novocure Has Already Doubled in 2024. Can It Soar ... - AOL

   www.aol.com/finance/novocure-already-doubled...

   Novocure (NASDAQ: NVCR) and its international partner Zai Lab (NASDAQ: ZLAB) announced successful top-line results from the Panova-3 study on Dec. 2, 2024. In a nutshell, it showed that the ...

5. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   homepage.aol.com

   Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.

6. FDA Approves NovoCure's Portable Device Producing Tumor ... - AOL

   www.aol.com/fda-approves-novocures-portable...

   On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC ...

7. Alternating electric field therapy - Wikipedia

   en.wikipedia.org/wiki/Alternating_electric_field...

   Novocure Ltd. (Nasdaq: NVCR) was founded in 2000. As of December 2020, Novocure Ltd. has over 1000 employees and makes hundreds of millions of dollars in annual sales. Israeli Professor Yoram Palti, professor of physiology and biophysics at the Israel Institute of Technology, is the company's founder and chief technology officer.

8. Novocure's lung cancer device study raises concerns around ...

   www.aol.com/news/novocures-lung-cancer-device...

   Novocure plans to submit marketing application to the U.S. Food and Drug Administration in the second half of 2023 based on the data. Novocure's shares fell 34.2% to a more than three-year low of ...

9. News Main - AOL Sports

   lite.aol.com/news/us

   Today's Top U.S. News Story ACLU sues over Trump shutting down asylum access at the southern border Immigration advocacy groups are suing the Trump administration, saying they are illegally shutting down asylum access at the southern border and putting people fleeing war and persecution in harm’s way More »